Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cureus|January 13, 2026
Unmasking a Silent Persistent Hyaloid Artery: A Rare Cause of Vitreous Hemorrhage in an Elderly PatientEirini Maliagkani, Aikaterini Chatzara, Konstantina Chronopoulou, et al.Current Drug Safety|August 6, 2014
Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factorsIoannis Tservakis, Chryssanthi Koutsandrea, Dimitrios Papaconstantinou, et al.Cutaneous and Ocular Toxicology|September 9, 2014
Post-operative refractory cystoid macular edema in a vitrectomized eye treated with slow-release dexamethasone implant (Ozurdex)Ilias Georgalas, Petros Petrou, Dimitrios Papakonstantinou, et al.Therapeutics and Clinical Risk Management|May 14, 2009
Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumabIlias Georgalas, Dimitris Papaconstantinou, Ioannis Tservakis, et al.Clinical & Experimental Optometry|January 5, 2011
Pseudoxanthoma elasticum, ocular manifestations, complications and treatmentIlias Georgalas, Ioannis Tservakis, Dimitris Papaconstaninou, et al.European Journal of Ophthalmology|September 5, 2022
Branch retinal vein occlusion following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccineGeorgia Karageorgiou, Konstantina Chronopoulou, Ilias Georgalas, et al.Cutaneous and Ocular Toxicology|May 8, 2019
Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective studyLias Georgalas, Ioannis Tservakis, Eftychia Eleftheria Kiskira, et al.Cutaneous and Ocular Toxicology|March 25, 2011
Perfluorocarbon liquids in vitreoretinal surgery: a review of applications and toxicityIlias Georgalas, Ioannis Ladas, Ioannis Tservakis, et al.Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|May 17, 2018
Long-Term Results of Combination Treatment with Single-Dose Ranibizumab plus Photodynamic Therapy for Retinal Angiomatous ProliferationPanagiotis Malamos, Ioannis Tservakis, Menelaos Kanakis, et al.Pageof 1